Research ArticleOriginal Research

Modifying Provider Vitamin D Screening Behavior in Primary Care

Nigel L. Rozario, Alica Sparling, Ryan Burns, Andrew McWilliams, Jennifer H. Brady, Marc Kowalkowski and Jason Roberge
The Journal of the American Board of Family Medicine March 2020, 33 (2) 252-261; DOI: https://doi.org/10.3122/jabfm.2020.02.190323

References

  1. 1.↵
    First, do no harm: calculating health care waste in Washington state. 2018. Available from: https://www.wacommunitycheckup.org/media/47156/2018-first-do-no-harm.pdf. Accessed May 6, 2019.
  2. 2.↵
    1. Shahangian S,
    2. Alspach TD,
    3. Astles JR,
    4. Yesupriya A,
    5. Dettwyler WK
    . Trends in laboratory test volumes for Medicare Part B reimbursements, 2000–2010. Arch Pathol Lab Med 2014;138:189–203.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. LeBlanc ES,
    2. Zakher B,
    3. Daeges M,
    4. Pappas M,
    5. Chou R
    . Screening for vitamin D deficiency: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015;162:109–22.
    OpenUrl
  4. 4.↵
    1. LeBlanc ES,
    2. Desai M,
    3. Perrin N,
    4. et al
    . Vitamin D levels and menopause-related symptoms. Menopause 2014;21:1197–203.
    OpenUrl
  5. 5.↵
    1. Li G,
    2. Mbuagbaw L,
    3. Samaan Z,
    4. et al
    . Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 2014;99:757–67.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Gowda U,
    2. Mutowo MP,
    3. Smith BJ,
    4. Wluka AE,
    5. Renzaho AM
    . Vitamin D supplementation to reduce depression in adults: meta analysis of randomized controlled trials. Nutrition 2015;31:421–9.
    OpenUrlCrossRef
  7. 7.↵
    1. Bertone-Johnson ER,
    2. Powers SI,
    3. Spangler L,
    4. et al
    . Vitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trial. Am J Epidemiol 2012;176:1–13.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Straube S,
    2. Derry S,
    3. Straube C,
    4. Moore RA
    . Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2015:2015:CD007771.
    OpenUrl
  9. 9.↵
    1. Zhang Y,
    2. Fang F,
    3. Tang J,
    4. et al
    . Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ 2019;366:l4673.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. LeFevre ML,
    2. LeFevre NM
    . Vitamin D screening and supplementation in community-dwelling adults: common questions and answers. Am Fam Physician 2018;97:254–60.
    OpenUrl
  11. 11.↵
    1. Theodoratou E,
    2. Tzoulaki I,
    3. Zgaga L,
    4. Ioannidis JP
    . Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Final recommendation statement: vitamin D deficiency screening. 2014. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/vitamin-d-deficiency-screening. Accessed May 6, 2019.
  13. 13.↵
    BlueCross BlueShield of North Carolina FAQs Wellness Benefits Allow for USPSTF Approved Tests and Screenings. Available from: https://www.bluecrossnc.com/sites/default/files/document/attachment/providers/public/pdfs/news-and-information/news/FAQs%20well%20visit%20diag%20testing%20(003)%20(002).pdf. Accessed August 15, 2019.
  14. 14.↵
    1. Mafi JN,
    2. Russell K,
    3. Bortz BA,
    4. Dachary M,
    5. Hazel WA Jr.,
    6. Fendrick AM
    . Low-cost, high-volume health services contribute the most to unnecessary health spending. Health Aff (Millwood) 2017;36:1701–4.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Petrilli CM,
    2. Henderson J,
    3. Keedy JM,
    4. et al
    . Reducing unnecessary vitamin D screening in an academic health system: what works and when. Am J Med 2018;131:1444–8.
    OpenUrl
  16. 16.↵
    1. Felcher AH,
    2. Gold R,
    3. Mosen DM,
    4. Stoneburner AB
    . Decrease in unnecessary vitamin D testing using clinical decision support tools: making it harder to do the wrong thing. J Am Med Informat Assoc 2017;24:776–80.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Bejjanki H,
    2. Mramba LK,
    3. Beal SG,
    4. et al
    . The role of a best practice alert in the electronic medical record in reducing repetitive lab tests. CEOR 2018;10:611–8.
    OpenUrl
  18. 18.↵
    1. White AA,
    2. McKinney CM,
    3. Hoffman NG,
    4. Sutton PR
    . Optimizing vitamin D naming conventions in computerized order entry to support high-value care. J Am Med Inform Assoc 2017;24:172–5.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Naugler C,
    2. Hemmelgarn B,
    3. Quan H,
    4. et al
    . Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open 2017;5:E36–E39.
    OpenUrl
  20. 20.↵
    1. Ferrari R,
    2. Prosser C
    . Testing vitamin D levels and choosing wisely. JAMA Intern Med 2016;176:1019–20.
    OpenUrl
  21. 21.↵
    Established Office Patients. Established office patient’s E/M coding, EM evaluation and management coding, E&M documentation, 99214, 99213. Available from: https://emuniversity.com/EstablishedOfficePatients.html. Accessed August 13, 2019.
  22. 22.↵
    1. Rozario NL,
    2. Moore CG,
    3. McWilliams A
    . Interrupted time series power calculation using do loop simulations. 2017. Available from: https://support.sas.com/resources/papers/proceedings17/1339-2017.pdf. Accessed April 15, 2018.
  23. 23.↵
    1. Penfold RB,
    2. Zhang F
    . Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr 2013;13:S38–S44.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Gebski V,
    2. Ellingson K,
    3. Edwards J,
    4. Jernigan J,
    5. Kleinbaum D
    . Modelling interrupted time series to evaluate prevention and control of infection in healthcare. Epidemiol Infect 2012;140:2131–41.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Parienti JJ,
    2. Cattoir V,
    3. Thibon P,
    4. et al
    . Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. J Hosp Infect 2011;78:118–22.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Minerowicz C,
    2. Abel N,
    3. Hunter K,
    4. Behling KC,
    5. Cerceo E,
    6. Bierl C
    . Impact of weekly feedback on test ordering patterns. Am J Manag Care 2015;21:763–8.
    OpenUrl
  27. 27.↵
    Agency for Healthcare Research and Quality. Alert fatigue. https://psnet.ahrq.gov/primers/primer/28/alert-fatigue. 2019. Accessed August 2019.
  28. 28.↵
    1. Sacarny A,
    2. Barnett ML,
    3. Le J,
    4. Tetkoski F,
    5. Yokum D,
    6. Agrawal S
    . Effect of peer comparison letters for high-volume primary care prescribers of quetiapine in older and disabled adults: a randomized clinical trial. JAMA Psychiatry 2018;75:1003–11.
    OpenUrl
  29. 29.↵
    1. Hallsworth M,
    2. Chadborn T,
    3. Sallis A,
    4. et al
    . Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016;387:1743–52.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords